TrialInvestigational new drugs2012

A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research.

Do-Youn Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.